Inflammation as a Modifiable Driver of Ischemic Heart Disease: Mechanisms, Clinical Risks, and Evolving Therapeutic Options

    January 2025 in “ Journal of Carcinogenesis
    Anastasia V. Poznyak, Igor Alexandrovich Sobenin, Elizaveta Romanovna Korchagina, Olesya Olegovna Galanova, Sergey Alekseevich Protasov, and Alexander N. Orekhov
    Studysummary This review highlights the potential of anti-inflammatory therapies to reduce major adverse cardiac events in patients with ischemic heart disease, emphasizing that such treatments can be effective even without traditional lipid-lowering strategies.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community โ†’